Removing binding sites for an oncogene can slow down cancer cell growth

byUniversity of HelsinkiStrategy of the CGE method to lineage-trace cells with distinct genome editing events using sequence tags with silent or near-silent mutations. a, The CGE method uses a l

Updated on: January 02,2024

Removing binding sites for an oncogene can slow down cancer cell growth

byUniversity of HelsinkiStrategy of the CGE method to lineage-trace cells with distinct genome editing events using sequence tags with silent or near-silent mutations. a, The CGE method uses a l

Updated on:January 02,2024

Study discovers novel molecular mechanism driving chemoresistance and tumor recurrence in gastric cancer

by The University of Hong KongProposed model for chemoresistance driven by ADAR1-upregulated SCD1 in gastric cancer. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-38581-

Updated on: February 03,2024

Study discovers novel molecular mechanism driving chemoresistance and tumor recurrence in gastric cancer

by The University of Hong KongProposed model for chemoresistance driven by ADAR1-upregulated SCD1 in gastric cancer. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-38581-

Updated on:February 03,2024

Team develops AI model to improve patient response to cancer therapy

byAustralian National UniversityDr. Danh-Tai Hoang. Credit: The Australian National University (ANU).A new artificial intelligence (AI) tool that can help physicians to select the most suitable

Updated on: July 05,2024

Team develops AI model to improve patient response to cancer therapy

byAustralian National UniversityDr. Danh-Tai Hoang. Credit: The Australian National University (ANU).A new artificial intelligence (AI) tool that can help physicians to select the most suitable

Updated on:July 05,2024

A clear vision for cancer diagnosis

by Adam Zewe,Harvard UniversityFreshman Kavya Kopparapu created an artificial intelligence platform, called GlioVision, which uses a scanned glioblastoma tumor image to determine the cancer’s mo

Updated on: March 27,2024

A clear vision for cancer diagnosis

by Adam Zewe,Harvard UniversityFreshman Kavya Kopparapu created an artificial intelligence platform, called GlioVision, which uses a scanned glioblastoma tumor image to determine the cancer’s mo

Updated on:March 27,2024

Study identifies potential combination therapy for testing in deadly brain cancer

by Ludwig Cancer ResearchGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.014A Ludwig Cancer Research study has identified a combination of three existing dr

Updated on: February 01,2024

Study identifies potential combination therapy for testing in deadly brain cancer

by Ludwig Cancer ResearchGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.014A Ludwig Cancer Research study has identified a combination of three existing dr

Updated on:February 01,2024

Asbestos study highlights risk of Australian Capital Territory residents developing cancer

byAustralian National UniversityCredit: Unsplash/CC0 Public DomainNew datapublishedin the latest edition of the ACT Asbestos Health Study, led by The Australian National University (

Updated on: September 30,2024

Asbestos study highlights risk of Australian Capital Territory residents developing cancer

byAustralian National UniversityCredit: Unsplash/CC0 Public DomainNew datapublishedin the latest edition of the ACT Asbestos Health Study, led by The Australian National University (

Updated on:September 30,2024

Researchers develop new machete technique to slice into cancer genome and study copy number alterations

by Memorial Sloan Kettering Cancer CenterMACHETE enables efficient engineering of genomic deletions. a, Schematic of the MACHETE approach. WT, wild type; HA, homology arm; Puro, puromycin; pA, po

Updated on: February 18,2024

Researchers develop new machete technique to slice into cancer genome and study copy number alterations

by Memorial Sloan Kettering Cancer CenterMACHETE enables efficient engineering of genomic deletions. a, Schematic of the MACHETE approach. WT, wild type; HA, homology arm; Puro, puromycin; pA, po

Updated on:February 18,2024

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Updated on: March 20,2024

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Updated on:March 20,2024

Active substance from plant slows down aggressive eye cancer

by University of BonnCredit: CC0 Public DomainAn active substance that has been known for 30 years could unexpectedly turn into a ray of hope against eye tumors. This is shown by a study conducte

Updated on: April 10,2024

Active substance from plant slows down aggressive eye cancer

by University of BonnCredit: CC0 Public DomainAn active substance that has been known for 30 years could unexpectedly turn into a ray of hope against eye tumors. This is shown by a study conducte

Updated on:April 10,2024

Molecular culprit behind virus-mediated chronic inflammation and cancers identified

by Public Library of ScienceBC-3 cells were stained with DAPI, anti-vFLIP, anti-CADM1, and cholera toxin B conjugated with red fluorescence to detect GM-1 and subjected to confocal microscopy. Cr

Updated on: March 01,2024

Molecular culprit behind virus-mediated chronic inflammation and cancers identified

by Public Library of ScienceBC-3 cells were stained with DAPI, anti-vFLIP, anti-CADM1, and cholera toxin B conjugated with red fluorescence to detect GM-1 and subjected to confocal microscopy. Cr

Updated on:March 01,2024

Discovery could lead to higher immunotherapy response rates for bladder cancer patients

by The Mount Sinai HospitalCredit: CC0 Public DomainMount Sinai researchers have discovered that a particular type of cell present in bladder cancer may be the reason why so many patients do not

Updated on: April 14,2024

Discovery could lead to higher immunotherapy response rates for bladder cancer patients

by The Mount Sinai HospitalCredit: CC0 Public DomainMount Sinai researchers have discovered that a particular type of cell present in bladder cancer may be the reason why so many patients do not

Updated on:April 14,2024

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho

Updated on: March 30,2024

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho

Updated on:March 30,2024